Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
cis-urocanic acid (2 trials)
tacrolimus (prograf) (1 trial)
Dermatitis (Phase 2)
Dermatitis, Atopic (Phase 2)
Eczema (Phase 2)
Urinary Bladder Neoplasms (Phase 1)
Trials (2 total)
Trial APIs (2 total)